New laser-ointment combo could zap skin cancer without the knife

NCT ID NCT07010692

Recruiting now Disease control Sponsor: Bruce Robinson, MD Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 18, 2026 · Updated 29 times

Summary

This study tests whether using fractional lasers followed by tirbanibulin ointment can effectively treat two common types of skin cancer: squamous cell carcinoma and basal cell carcinoma. About 100 adults with biopsy-confirmed skin cancers will receive the laser treatment and then apply the ointment for five nights. The goal is to clear the cancer while avoiding invasive surgery, improving how the skin looks afterward, and offering a simpler option for more people.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SQUAMOUS CELL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Bruce Robinson, MD
RECRUITING

New York, New York, 10022, United States

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

BASAL CELL CARCINOMAS BASAL CELL CARCINOMAS KERATINOCYTE CARCINOMA SKIN CANCER SQUAMOUS CELL CARCINOMA SQUAMOUS CELL CARCINOMA